E. Fidan Et Al. , "Thrombin activatable fibrinolysis inhibitor and thrombin-antithrombin-III-complex levels in patients with gastric cancer," TUMOR BIOLOGY , vol.33, no.5, pp.1519-1525, 2012
Fidan, E. Et Al. 2012. Thrombin activatable fibrinolysis inhibitor and thrombin-antithrombin-III-complex levels in patients with gastric cancer. TUMOR BIOLOGY , vol.33, no.5 , 1519-1525.
Fidan, E., Kavgaci, H., ÖREM, A., YILMAZ, M., Yildiz, B., FIDAN, S., ... AKCAN, B.(2012). Thrombin activatable fibrinolysis inhibitor and thrombin-antithrombin-III-complex levels in patients with gastric cancer. TUMOR BIOLOGY , vol.33, no.5, 1519-1525.
Fidan, EVREN Et Al. "Thrombin activatable fibrinolysis inhibitor and thrombin-antithrombin-III-complex levels in patients with gastric cancer," TUMOR BIOLOGY , vol.33, no.5, 1519-1525, 2012
Fidan, EVREN Et Al. "Thrombin activatable fibrinolysis inhibitor and thrombin-antithrombin-III-complex levels in patients with gastric cancer." TUMOR BIOLOGY , vol.33, no.5, pp.1519-1525, 2012
Fidan, E. Et Al. (2012) . "Thrombin activatable fibrinolysis inhibitor and thrombin-antithrombin-III-complex levels in patients with gastric cancer." TUMOR BIOLOGY , vol.33, no.5, pp.1519-1525.
@article{article, author={EVREN FİDAN Et Al. }, title={Thrombin activatable fibrinolysis inhibitor and thrombin-antithrombin-III-complex levels in patients with gastric cancer}, journal={TUMOR BIOLOGY}, year=2012, pages={1519-1525} }